Literature DB >> 18500495

Successful treatment of hyperventilation-induced nystagmus in vestibular schwannoma with oxcarbacepine.

Guido Ahle, Wenke Visser, Annika Juergens, Uwe Schlegel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500495     DOI: 10.1007/s00415-008-0842-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Hyperventilation-induced nystagmus in patients with vestibular schwannoma.

Authors:  L B Minor; T Haslwanter; D Straumann; D S Zee
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

2.  Hyperventilation-induced nystagmus in vestibular schwannoma.

Authors:  Kwang-Dong Choi; Hyun Ji Cho; Ja-Won Koo; Seong-Ho Park; Ji Soo Kim
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

3.  Vestibular paroxysmia: vascular compression of the eighth nerve?

Authors:  T Brandt; M Dieterich
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

Review 4.  Assessing vestibular function: which tests, when?

Authors:  M Fetter
Journal:  J Neurol       Date:  2000-05       Impact factor: 4.849

5.  Vestibular disease unmasked by hyperventilation.

Authors:  M L Bance; M O'Driscoll; N Patel; R T Ramsden
Journal:  Laryngoscope       Date:  1998-04       Impact factor: 3.325

Review 6.  EFNS task force--therapy of nystagmus and oscillopsia.

Authors:  A Straube; R J Leigh; A Bronstein; W Heide; P Riordan-Eva; C C Tijssen; I Dehaene; D Straumann
Journal:  Eur J Neurol       Date:  2004-02       Impact factor: 6.089

  6 in total
  1 in total

1.  Hyperventilation-induced nystagmus in vestibular schwannoma and unilateral sensorineural hearing loss.

Authors:  Marco Mandalà; Annalisa Giannuzzi; Serena Astore; Franco Trabalzini; Daniele Nuti
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-30       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.